Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among high-risk patients with mild to moderate COVID-19

• Main Authors: Abraham Ka-Chung Wai (Author), Crystal Ying Chan (Author), Annie Wai-Ling Cheung (Author), Kailu Wang (Author), Sunny Ching-Long Chan (Author), Teddy Tai-Loy Lee (Author), Luke Yik-Fung Luk (Author), Edmond Tsz-Fung Yip (Author), Joshua Wing-Kei Ho (Author), Omar Wai-Kiu Tsui (Author), Kelly Wing-Yin Cheung (Author), Shiyeow Lee (Author), Chak-kwan Tong (Author), Tafu Yamamoto (Author), Timothy Hudson Rainer (Author), Eliza Lai-Yi Wong (Author)
• Format: Book
• Published: Elsevier, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Real-world data is currently limited on the association between oral antiviral therapy and healthcare system burden in patients with mild-to-moderate COVID-19. This study aims to evaluate the clinical and cost effectiveness of Molnupiravir and Nirmatrelvir-ritonavir use in reduc...